Table 4 Female age subgroup analysis ≤ 35 years vs. >35 years.
Group I (No r-LH) | Group II (r-LH) | |||
|---|---|---|---|---|
≤ 35 years | > 35 years | ≤ 35 years | > 35 years | |
Patients | 90 | 32 | 90 | 32 |
Cycles | 90 | 32 | 90 | 32 |
Transfers | 84 | 30 | 89 | 30 |
Total dose r-FSH (IU) | 1976.7 ± 583.3 | 2756.3 ± 760.6 | 1873.6 ± 546.2 | 2477.3 ± 721.8 |
Total dose r-LH (IU) | ------ | ------ | 1034.2 ± 245.9 | 1087.5 ± 302.4 |
Retrieved oocytes | 10.4 ± 4.7 | 6.4 ± 3.4 | 11.9 ± 5.8 | 8.1 ± 5.2 |
Immature oocytes | 3.0 ± 2.9 | 1.6 ± 1.4 | 2.6 ± 2.9 | 1.9 ± 2.5 |
Metaphase II Oocyte | 7.4 ± 4.3a | 4.8 ± 3.0 | 9.3 ± 4.5a | 6.7 ± 4.5 |
Fertilization rate | 67.8%b | 58.7% | 72.5%b | 65.2% |
Embryos/cycle (n) | 5.9 ± 3.7c | 3.2 ± 2.0 | 7.6 ± 4.1c | 4.6 ± 3.2 |
embryos transferred (n) | 2.0 ± 0.7 | 2.1 ± 0.9 | 2.0 ± 0.3 | 2.0 ± 0.9 |
frozen embryos per cycle(n) | 3.7 ± 3.9d | 1.1 ± 2.1e | 5.0 ± 3.8d | 2.8 ± 3.3e |
Implantation rate | 18.3% | 16.7% | 25.8% | 15.4% |
Pregnancy rate | ||||
-per patient | 27.8% | 34.4% | 36.7% | 25% |
-per transfer | 29.8% | 36.7% | 37.1% | 26.7% |
Miscarriage rate | 8% | 18.2% | 15.2% | 12.5% |
Live birth/patient (or started cycle | 24.4% | 21.9% | 28.9% | 21.9% |